Differential Effects of Acute and Chronic Fluoxetine Administration on the Spontaneous Activity of Dopaminergic Neurones in the Ventral Tegmental Area

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1995 Sep 1

PMID 8528581

Citations 40

Authors

S Prisco

E Esposito

Affiliations

Soon will be listed here.

Abstract

1. Electrophysiological techniques were used to study the effects of fluoxetine and citalopram on the basal activity of dopaminergic neurones in the ventral tegmental area (VTA) and substantia nigra, pars compacta (SNc) of rats. 2. Acute i.v. injection of fluoxetine (20-1280 micrograms kg-1) caused a dose-dependent inhibition of the firing rate of VTA dopaminergic neurones, but did not affect the activity of dopaminergic cells in the SNc. Citalopram (20-1280 micrograms kg-1, i.v.) inhibited the firing rate of dopaminergic neurones in the VTA, but its effect (maximal inhibition: 14 +/- 7%) was less pronounced than that of fluoxetine (maximal inhibition: 34 +/- 7%). 3. Pretreatment with mesulergine (80 micrograms kg-1, i.v.), a 5-hydroxytryptamine2C/2B (5-HT2C/2B) receptor antagonist, blocked the inhibitory effect of fluoxetine on VTA dopaminergic cells. Selective lesions of 5-hydroxytryptaminergic neurones by the neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT), abolished the fluoxetine-induced reduction of VTA dopaminergic activity. 4. In a series of experiments, fluoxetine (10 mg kg-1, i.p.) was administered once daily for 21 consecutive days. Acute i.v. administration of fluoxetine (20-1280 micrograms kg-1, 72 h after the last i.p. injection) did not cause any change in the basal firing rate of VTA dopaminergic neurones in treated rats, whereas it induced the typical inhibitory effect in control animals. A group of rats chronically treated with fluoxetine, received i.v. m-chlorophenylpiperazine (mCPP; 10-320 micrograms kg-1), a 5-HT2C/2B receptor agonist. This drug significantly inhibited VTA dopaminergic function in control rats, but did not modify the basal activity of dopaminergic cells in animals given chronic fluoxetine. 5 It is concluded that fluoxetine inhibits dopaminergic function in the VTA by enhancing the synaptic levels of 5-HT, which possibly acts through the 5-HT2C/2B receptor subtype. Repeated treatment with fluoxetine induces tolerance to its inhibitory effect on dopaminergic activity, possibly as a consequence of down-regulation of 5-HT2C/2B receptors. The effects of fluoxetine on VTA dopaminergic cell activity might be relevant for its therapeutic actions and may explain the origin of the reported cases of akathisia.

Citing Articles

Evaluation of the 5-HT receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction.

Jastrzebska J, Frankowska M, Smaga I, Hubalewska-Mazgaj M, Suder A, Pieniazek R Pharmacol Rep. 2022; 75(1):99-118.

PMID: 36374478 PMC: 9889480. DOI: 10.1007/s43440-022-00428-2.

Spotlight on Oculogyric Crisis: A Review.

Mahal P, Suthar N, Nebhinani N Indian J Psychol Med. 2021; 43(1):5-9.

PMID: 34349300 PMC: 8295578. DOI: 10.1177/0253717620942096.

Information capacity and robustness of encoding in the medial prefrontal cortex are modulated by the bioavailability of serotonin and the time elapsed from the cue during a reward-driven task.

Pereyra A, Mininni C, Zanutto B Sci Rep. 2021; 11(1):13882.

PMID: 34230550 PMC: 8260631. DOI: 10.1038/s41598-021-93313-6.

Lateral Habenula 5-HT Receptor Function Is Altered by Acute and Chronic Nicotine Exposures.

Bombardi C, Delicata F, Tagliavia C, Grandis A, Pierucci M, Marino Gammazza A Int J Mol Sci. 2021; 22(9).

PMID: 33946328 PMC: 8124296. DOI: 10.3390/ijms22094775.

Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico-Striatal Loop That Are Implicated in Major Depression.

Ferber S, Weller A, Yadid G, Friedman A Int J Mol Sci. 2021; 22(4).

PMID: 33668515 PMC: 7918043. DOI: 10.3390/ijms22041867.

References

Moore R, Bloom F . Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci. 1978; 1:129-69. DOI: 10.1146/annurev.ne.01.030178.001021. View

Thomas D, Nelson D, Johnson A . Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology (Berl). 1987; 93(2):193-200. DOI: 10.1007/BF00179933. View

Cervo L, Samanin R . Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens. J Pharm Pharmacol. 1988; 40(2):155-6. DOI: 10.1111/j.2042-7158.1988.tb05208.x. View

Hoyer D . Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res. 1988; 8(1-4):59-81. DOI: 10.3109/10799898809048978. View

Kennett G, Curzon G . Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol. 1988; 94(1):137-47. PMC: 1853919. DOI: 10.1111/j.1476-5381.1988.tb11508.x. View

Sinton C, Fallon S . Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur J Pharmacol. 1988; 157(2-3):173-81. DOI: 10.1016/0014-2999(88)90380-9. View

Tate J . Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. Am J Psychiatry. 1989; 146(3):399-400. DOI: 10.1176/ajp.146.3.399b. View

Lipinski Jr J, Mallya G, Zimmerman P, Pope Jr H . Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry. 1989; 50(9):339-42. View

Levine R, Hoffman J, Knepple E, Kenin M . Long-term fluoxetine treatment of a large number of obsessive-compulsive patients. J Clin Psychopharmacol. 1989; 9(4):281-3. View

10.

Bunney B, Walters J, Roth R, Aghajanian G . Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther. 1973; 185(3):560-71. View

11.

Baumgarten H, Bjorklund A, Lachenmayer L, Nobin A . Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta Physiol Scand Suppl. 1973; 391:1-19. View

12.

Aghajanian G . LSD and 2-bromo-LSD: comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala. Neuropharmacology. 1976; 15(9):521-8. DOI: 10.1016/0028-3908(76)90102-7. View

13.

Samanin R, Bernasconi S, Garattini S . The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats. Eur J Pharmacol. 1975; 34(2):377-80. DOI: 10.1016/0014-2999(75)90266-6. View

14.

Azmitia E, Segal M . An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 1978; 179(3):641-67. DOI: 10.1002/cne.901790311. View

15.

Delean A, Munson P, Rodbard D . Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978; 235(2):E97-102. DOI: 10.1152/ajpendo.1978.235.2.E97. View

16.

Meltzer H, Young M, Metz J, Fang V, Schyve P, Arora R . Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm. 1979; 45(2):165-75. DOI: 10.1007/BF01250091. View

17.

Phillipson O . Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat. J Comp Neurol. 1979; 187(1):117-43. DOI: 10.1002/cne.901870108. View

18.

Wong D, Horng J, Bymaster F, Hauser K, Molloy B . A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 1974; 15(3):471-9. DOI: 10.1016/0024-3205(74)90345-2. View

19.

White R . Psychotherapy with schizophrenic patients. Am J Psychiatry. 1989; 146(10):1353-4. DOI: 10.1176/ajp.146.10.aj146101353. View

20.

Baldessarini R, Marsh E . Fluoxetine and side effects. Arch Gen Psychiatry. 1990; 47(2):191-2. DOI: 10.1001/archpsyc.1990.01810140091015. View